| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/19/1995 | CN1105239A An ocular hypotensive agent |
| 07/19/1995 | CN1105238A Medicinal composition for resisting virus AIDS |
| 07/19/1995 | CN1105237A Aspirin chewing gum |
| 07/19/1995 | CN1105235A Oral compositions for plaque and gingivitis |
| 07/19/1995 | CN1105205A Nourishing food rich in DHA and active calcium for tonifying brain and benefiting intelligence and preparing process thereof |
| 07/19/1995 | CA2140498A1 Method for preventing or reducing risk of onset of cardiovascular events employing an hmg coa reductase |
| 07/19/1995 | CA2113683A1 Treatment of proliferative disorders, metastases, and drug resistant tumors with vanadate compounds and derivatives or analogues thereof |
| 07/18/1995 | US5434292 Phenylalkanoic acid derivatives, process for producing the same and process for separating optical isomers thereof |
| 07/18/1995 | US5434265 Inhibitors of HIV protease |
| 07/18/1995 | US5434260 Carbamates of rapamycin |
| 07/18/1995 | US5434258 δ1,4 -pregnadiene-3,20-diones |
| 07/18/1995 | US5434186 Antiinflammatory agents |
| 07/18/1995 | US5434185 Method for inhibiting angiogenesis with aurintricarboxylic acid, its analogues or salts |
| 07/18/1995 | US5434184 Chemical compounds |
| 07/18/1995 | US5434183 Phospholipids containing omega-3-fatty acids |
| 07/18/1995 | US5434182 Antibacterial fatty acid compositions |
| 07/18/1995 | US5434180 Skin disorders; retinoid activity; rheumatoid psoriasis; |
| 07/18/1995 | US5434179 Enzyme inhibitors |
| 07/18/1995 | US5434178 1,3,5 trisubstituted pyrazole compounds for treatment of inflammation |
| 07/18/1995 | US5434177 Imidazoles for the treatment of age-related cognitive disorders and alzheimer |
| 07/18/1995 | US5434176 Phenylimidazolidines |
| 07/18/1995 | US5434174 Isoxazole derivatives for the treatment of irritable bowel syndrome |
| 07/18/1995 | US5434173 Heteroaryl substituted phenylethenyl compounds having retinoid-like biological activity |
| 07/18/1995 | US5434172 Sulfonamide derivatives |
| 07/18/1995 | US5434171 Preparation of 3,4,4-trisubstituted-piperidinyl-N-alkylcarboxylates and intermediates |
| 07/18/1995 | US5434170 Administering thalidomide for treatment of Alzheiemer's disease |
| 07/18/1995 | US5434169 Piperidine derivatives, their preparation and their application in therapy |
| 07/18/1995 | US5434168 4-[(2-benzothiazolyl)methylamino]-alpha-[(3,4-difluorophenoxy)methyl]-1-piperidineethanol |
| 07/18/1995 | US5434167 Imidazolines N-substituted by a biphenylmethyl group, their medical use and the pharmaceutical compositions therefor |
| 07/18/1995 | US5434166 Methods of inhibiting demyelinating and desmyelinating diseases |
| 07/18/1995 | US5434164 Carbostyril derivatives and salts thereof and pharmaceutical compositions for inhibiting adhesion of thrombocytes |
| 07/18/1995 | US5434163 Treatment of Cryptococcus neoformans infection |
| 07/18/1995 | US5434162 Quinolinyl/isoquinolinyl-terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension |
| 07/18/1995 | US5434161 Imidazopyridines as serotonergic 5-HT3 antagonists |
| 07/18/1995 | US5434160 Autoimmune diseases; prevention of excess cell proliferation or enzyme release |
| 07/18/1995 | US5434158 Asthma |
| 07/18/1995 | US5434156 Use of diphenylbutyl-piperazinecarboxamides in the treatment of substance disorders |
| 07/18/1995 | US5434155 Quinoline derivative fumarates |
| 07/18/1995 | US5434154 Serotonin agonists |
| 07/18/1995 | US5434153 Cardiovascular disorders |
| 07/18/1995 | US5434151 Compounds and methods for the treatment of disorders mediated by platelet activating factor or products of 5-lipoxygenase |
| 07/18/1995 | US5434150 Anticoagulants, cardiovascular disorders |
| 07/18/1995 | US5434149 Phosphodiesterase inhibitors |
| 07/18/1995 | US5434146 Antitumor, breast cancer |
| 07/18/1995 | US5434145 N-alkythio polyamine derivatives as radioprotective agents |
| 07/18/1995 | US5434144 Methods of using cyclic polyanionic polyol derivatives for regulating skin wrinkles |
| 07/18/1995 | US5434142 Method of treatment for muscular dystrophy |
| 07/18/1995 | US5434141 Medicament for the treatment of hyperlipidaemia and/or atherosclerosis |
| 07/18/1995 | US5434140 Antibiotic derivatives |
| 07/18/1995 | US5433959 Antisecretory agent such as lansoprazole stabilized by basic inorganic salts |
| 07/18/1995 | US5433955 Site specific in vivo activation of therapeutic drugs |
| 07/18/1995 | US5433954 Nickel compounds |
| 07/18/1995 | US5433953 Interfacial polymerization, polyureas, incorporation of quaternary ammonium type antiseptic into latex |
| 07/18/1995 | CA2037596C Rebeccamycin analog by bromide precursor feeding |
| 07/18/1995 | CA1336333C Pyrrolidone-2 compounds and their use for central analgesic activity |
| 07/18/1995 | CA1336326C Microbeads of diltiazem, a process for their manufacture and a sustained-release pharmaceutical composition containing them |
| 07/18/1995 | CA1336325C Rolled matrix device having enhanced ability to unroll and method for its production |
| 07/18/1995 | CA1336323C Process for the preparation of anti-inflammatory pharmaceutical agents with an ibuprofen base, with elimination, in solution, of the bitter taste, burning of the throat and intestinal toxicity |
| 07/15/1995 | CA2139720A1 Sulfuric acid esters of sugar alcohols |
| 07/13/1995 | WO1995018863A1 Composition containing nucleic acids, preparation and uses |
| 07/13/1995 | WO1995018860A1 Control of marek's disease by the inhibition of latency and tumor cell development |
| 07/13/1995 | WO1995018856A1 Vertebrate embryonic pattern-inducing hedgehog-like proteins |
| 07/13/1995 | WO1995018854A1 Ribozymes targeting the retroviral packaging sequence expression constructs and recombinant retroviruses containing such constructs |
| 07/13/1995 | WO1995018840A1 Surface modified medical devices |
| 07/13/1995 | WO1995018826A2 Purified primate ctla-8 antigens and related reagents |
| 07/13/1995 | WO1995018821A2 Novel antiandrogenic agents and related pharmaceutical compositions and methods of use |
| 07/13/1995 | WO1995018820A1 Monomeric diols and phosphate linked oligomers formed therefrom |
| 07/13/1995 | WO1995018815A1 Monohydrate of (e)-2'-deoxy-2'-(fluoromethylene)cytidine |
| 07/13/1995 | WO1995018810A1 Hydrazides of phosphorylated carboxylic acids having therapeutic activity |
| 07/13/1995 | WO1995018808A1 Cyclic polyamines |
| 07/13/1995 | WO1995018807A1 Novel 3-(substituted methyl)-4-oxa-1-azabicyclo[3.2.0]heptan-7-one derivatives useful as antitumor agents |
| 07/13/1995 | WO1995018804A1 Water soluble onium salt of taxo-diterpenoid |
| 07/13/1995 | WO1995018803A1 Acetylenes disubstituted with a phenyl or heteroaryl group and a 2-oxochromanyl, 2-oxothiochromanyl or 2-oxo-1,2,3,4-tetrahydroquinolinyl group having retinoid-like activity |
| 07/13/1995 | WO1995018799A1 Phenyl heterocycles as cox-2 inhibitors |
| 07/13/1995 | WO1995018797A1 Novel serine protease inhibitors: derivatives of isothiazolidin-3-one-1,1 dioxide and 3-oxo-1,2,5-thiadiazolidine-1,1-dioxide |
| 07/13/1995 | WO1995018794A1 Novel optionally substituted phenylimidazolidines, intermediates and process for their preparation, their use as drugs and pharmaceutical compositions containing them |
| 07/13/1995 | WO1995018793A1 Novel heterocyclic compounds |
| 07/13/1995 | WO1995018792A1 Pyrrolidine-containing monomers and oligomers |
| 07/13/1995 | WO1995018791A1 Pharmaceutical formulations comprising polythiourea and method of use thereof |
| 07/13/1995 | WO1995018629A1 Method for treatment and prevention of disease in animals |
| 07/13/1995 | WO1995018625A1 The composition containing snapping turtle and tortoise, the preparation and the use thereof |
| 07/13/1995 | WO1995018623A1 Oligomeric compounds having nitrogen-containing linkages |
| 07/13/1995 | WO1995018622A1 Use of 2-hydroxy-5-phenylazobenzoic acid derivatives as colon cancer chemopreventative and chemotherapeutic agents |
| 07/13/1995 | WO1995018621A1 Methods of inhibiting angiogenesis and tumor growth, and treating ophthalmologic conditions with angiostatic and therapeutic steroids |
| 07/13/1995 | WO1995018620A1 Treatment using arachidonic acid metabolite and particulate formulations |
| 07/13/1995 | WO1995018619A1 Bicyclic fibrinogen antagonists |
| 07/13/1995 | WO1995018618A2 Enteral formula with ribo-nucleotides |
| 07/13/1995 | WO1995018617A1 1-aminoindan derivatives and compositions thereof |
| 07/13/1995 | WO1995018616A2 8-aza, 6-aza and 6,8-diaza-1,4-dihydroquinoxaline-2,3-diones and the use thereof as antagonists for the glycine/nmda receptor |
| 07/13/1995 | WO1995018615A1 A method of treating neurogenic inflammation |
| 07/13/1995 | WO1995018614A1 Method for treatment of obesity using prolactin modulators and diet |
| 07/13/1995 | WO1995018613A1 Self-assembled taxo-diperpenoid nanostructures |
| 07/13/1995 | WO1995018612A1 A method for treatment of psoriasis, by omeprazole or related compounds |
| 07/13/1995 | WO1995018611A1 3-(7-oxo-1-aza-4-oxabicyclo[3.2.0]hept-3-yl) alanine derivative as antitumor agent |
| 07/13/1995 | WO1995018610A1 Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders |
| 07/13/1995 | WO1995018609A1 Human leukocyte 12-lipoxygenase, mediation of its pathway, and consequences thereof |
| 07/13/1995 | WO1995018608A1 Method of treating disorders of the animal or human body by administering amino acids |
| 07/13/1995 | WO1995018607A1 Pharmaceutical compositions |
| 07/13/1995 | WO1995018606A1 Curcumin, analogues of curcumin and novel uses thereof |
| 07/13/1995 | WO1995018604A1 Topical treatment of ocular photophobia |